Abstract
The aim of the research study was to investigate the ability of Soluplus® and surfactant individually as well as in combination to improve the solubility, subsequently the dissolution profile of lornoxicam (LORX). A laboratory size single screw rotating extruder with temperature and speed control parameters employed during hot melt extrusion (HME) processing of LORX along with polymer-surfactant blends. Soluplus® used as primary solubilizing agent for preparing solid dispersion (SD). Along with Soluplus® different concentrations of surfactants such as PEG 400, Lutrol F127, Lutrol F68 were used to solve the permeability issues related to LORX. Encapsulation of LORX particles inside the molten matrix of polymer-excipient blend was confirmed by DSC, XRD and FT-IR. Drug excipient microscopic interaction was further confirmed by scanning electron microscopy (SEM). Depending upon the ratio of the polymer and surfactants used, the solubility of the hot melt extruded LORX was improved and found to be in the range 35–86 μg/ml (actual aqueous solubility of LORX was found to be 0.0083 μg/ml). Dissolution profile of the extruded SD was improved and was found to be in the range of 98–104 % within 20 min (actual dissolution profile of LORX was found to be 8 % at the end of 1 h). SEM and Raman images suggest the formation of amorphous dispersion systems. SD was subjected to stability studies as per ICH guidelines and found to be stable after 6 months when analyzed by HPLC. SD prepared from HME significantly improves the solubility and dissolution profile of LORX—a BCS class II drug.
Similar content being viewed by others
References
Almeida A, Saerens L, De Beer T, Remon JP, Vervaet C (2012) Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm 439:223–229. doi:10.1016/j.ijpharm.2012.09.037
Biswal S, Sahoo J, Murthy PN, Giradkar RP, Avari JG (2008) Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. AAPS PharmSciTech 9:563–570
Bramhane DM, Saindane NS, Vavia PR (2011) Inclusion complexation of weakly acidic NSAID with β-cyclodextrin: selection of arginine, an amino acid, as a novel ternary component. J Incl Phenom Macrocycl Chem 69:453–460
Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eu J Pharm Biopharm 54:107–117
Burugu R (2011) Stability-indicating LC method for analysis of lornoxicam in the finished dosage form. Int J Pharm Pharm Sci 3:318–322
Chemete SZ (2012) A factorial study on enhancement of solubility and dissolution rate of lornoxicam employing Hp-β-cyclodextrin and surfactants. Int J Pharm Sci Res 3(7):2252–2256
Chokshi RJ, Malick WA (2007) Improving the dissolution rate of poorly water soluble drug by SD and solid solution. Drug Deliv 14(1):33–45
Forster A, Hempenstall J, Tucker I, Rades T (2001) Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. Int J Pharm 226:147–161
Fu J, Zhang L (2010) Stable nimodipine tablets with high bioavailability containing NM-SD prepared by hot-melt extrusion. Powder Technol 204:214–221
Fule RA, Amin PD (2013a) Artemether-soluplus hot-melt extrudate solid dispersion systems for solubility and dissolution rate enhancement with amorphous state characteristics. J Pharm 1:1–15
Fule RA, Amin PD (2013b) Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation. J Pharm Inv 43:305–321
Gavin PA, Osama AD (2010) Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharm 62:1580–1590
Greenhalgh DJ, Timmins PY (1999) Solubility parameters as predictors of miscibility in SD. J Pharm Sci 88:1182–1190
Higuchi T, Connors K (1965) Phase-solubility techniques. Adv Anal Chem Instrum Tech 4:117–130
Jung JY (1999) Enhanced solubility and dissolution rate of itraconazole by a SD technique. Int J Pharm 187:209–218
Kalogeras IM (2011) A novel approach for analysing glass-transition temperature vs. composition patterns: application to pharmaceutical compound + polymer systems. Eur J Pharm Sci 42:470–483
Kharwade M (2012) Solubility behavior of lornoxicam in binary solvents of pharmaceutical interest. J Sol Chem 41(8):1364–1374
Konno H, Taylor LS (2006) Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95:2692–2705
Leuner C, Dressman J (2000) Improving drug solubility for oral delivery using SD. Eur J Pharm Biopharm 50:47–60
Linn M (2012) Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro. Eu J Pharm Sci 45:336–343
Maniruzzaman M, Morgan DJ, Douroumis D (2013) Drug–polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 443:199–208
Modi A (2006) Enhancement of dissolution profile by solid dispersion (Kneading) technique. AAPS PharmSciTech 7(3):1–6
Osama AA, David SJ (2012) Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods. J Pharm Sci 101:200–213
Pan RN (2000) Enhancement of dissolution and bioavailability of Piroxicam in solid dispersion system. Drug Dev Ind Pharm 26(9):989–994
Prajapati P (2012) Azeotropic mixture used for development and validation of lornoxicam in bulk and its tablet dosage form by spectrophotometric method. J Pharm Anal 2:306–309
Saerens L, Dierickx L, Lenain B (2011) Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm 77:158–163
Sathigari SK, Radhakrishnan VK, Davis VA, Parsons DL, Jayachandra BR (2012) Amorphous-state characterization of efavirenz—polymer hot-melt extrusion systems for dissolution enhancement. J Pharm Sci 101:3456–3464
Serajuddin Abu TM (1999) Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharma Sci 88:1058–1066
Singla K (2012) Preparation and evaluation of lornoxicam niosomal gel. Int Res J Pharm 3(4):378–383
Vasconcelos T, Sarmento B (2007) SD as strategy to improve oral bioavailability of poorly water soluble drugs. Drug Discov Today 12:1068–1075
Xie Y (2009) Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. AAPS PharmSciTech 10(2):631–640
Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG (2012) Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 422:202–210
Yang J, Gray K, Doney J (2010) An improved kinetics approach to describe the physical stability of amorphous SD. Int J Pharm 384:24–31
Zsombor KN, Attila B (2012) Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 101:322–332. doi:10.1002/jps.22731
Acknowledgments
The authors are thankful to Alkem Pharmaceuticals Ltd., India for providing the gift sample of LORX, BASF Ltd. Mumbai for the gift sample of Soluplus®, Lutrol® F127 and Lutrol® F68. The author is also thankful to UGC (SAP) for providing the research fellowship and Institute of Chemical Technology, ELITE status (Mumbai, India) for providing all facilities and guidance.
Conflict of interest
None.
Compliance with ethical requirements
This article dose not contain any studies with human and animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fule, R., Meer, T., Amin, P. et al. Preparation and characterisation of lornoxicam solid dispersion systems using hot melt extrusion technique. Journal of Pharmaceutical Investigation 44, 41–59 (2014). https://doi.org/10.1007/s40005-013-0099-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-013-0099-7